The approval is supported by a combination of current clinical data and model-informed drug development techniques.

For more helpful resources and information on bipolar I disorder, visit LightsCameraAdvocacy.com. As of 2020, approximately 21% of all U.S. adults reported living with a mental illness. Though not ...

Purposeful prescribing is the idea of making thoughtful, patient-centred decisions about medication – choices that reflect ...

The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I ...

Mood tracking can be an effective tool for managing and preventing bipolar disorder episodes. Here’s how it works. Living with bipolar disorder can be overwhelming at times. The shifts between ...